Alzhraa Salah Abbas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alzhraa Salah Abbas has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Sherief Ghozy
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
8 shared publications - Amr Ehab El-Qushayri
Faculty of Medicine, Minia University, Minia, Egypt
4 shared publications - Laura E. Breeher
Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN
3 shared publications - Nguyen Tien Huy
Institute of Research and Development Duy Tan University Da Nang Vietnam
3 shared publications Abdalla Reda Mahmoud
Faculty of Medicine, Minia University, Minia, Egypt
2 shared publicationsAbdullah Dahy
Faculty of Medicine, Minia University, Minia, Egypt
2 shared publications
Latest Publications
- 19 November 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
Reproductive Outcomes in a Longitudinal Hazardous Medication Surveillance Program Among Healthcare Workers
Objective: We evaluated a Hazardous Medication Surveillance Program (HMSP) with analysis of reproductive outcomes. Methods: The HMSP included a biennial questionnaire and a complete blood count. Invited healthcare personnel (HCP) were anticipated to handle hazardous medications ≥2 times/week, >26 weeks/year. Two consecutive surveillance cycles were compared using chi-square or Fisher exact testing. Reproductive outcomes were stratified by exposure time. Results: Cycles 1 and 2 included 2625 and 2057 participants (mean age of 31 vs 34; 81.4% female). Among females aged 18-44, adverse reproductive outcomes were 9.5% and 10.5% with miscarriage reported in 4.4% of HCP in cycle 2. Outcomes increased with exposure (p≥0.009). Conclusions: An exposure-outcome gradient supports exposure and age stratification in HMSPs. These findings highlight the need for safety programs and effective exposure-control strategies to reduce occupational risk among HCP handling hazardous medications.
- 19 November 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
Reproductive Outcomes in a Longitudinal Hazardous Medication Surveillance Program Among Healthcare Workers
Objective: We evaluated a Hazardous Medication Surveillance Program (HMSP) with analysis of reproductive outcomes. Methods: The HMSP included a biennial questionnaire and a complete blood count. Invited healthcare personnel (HCP) were anticipated to handle hazardous medications ≥2 times/week, >26 weeks/year. Two consecutive surveillance cycles were compared using chi-square or Fisher exact testing. Reproductive outcomes were stratified by exposure time. Results: Cycles 1 and 2 included 2625 and 2057 participants (mean age of 31 vs 34; 81.4% female). Among females aged 18-44, adverse reproductive outcomes were 9.5% and 10.5% with miscarriage reported in 4.4% of HCP in cycle 2. Outcomes increased with exposure (p≥0.009). Conclusions: An exposure-outcome gradient supports exposure and age stratification in HMSPs. These findings highlight the need for safety programs and effective exposure-control strategies to reduce occupational risk among HCP handling hazardous medications.
- Open Access
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
Analysis of a Standardized Approach to Healthcare Worker Hazardous Medication Surveillance: Lessons learned and future enhancements.
Objective: To evaluate the effectiveness of a standardized hazardous medication surveillance program and identify occupational factors associated with adverse health outcomes among healthcare workers (HCWs). Methods: We analyzed data from 2,625 HCWs enrolled in a multi-site surveillance program (2020–2022). Participants completed a standardized questionnaire and underwent complete blood count testing. Exposure was categorized by weekly time handling hazardous medications. Associations were evaluated using univariate and multivariable analyses. Results: Higher exposure (>8 hours/week) was associated with increased symptom reporting, hazardous medication spills, and adverse reproductive outcomes. Female sex, older age, and spill exposure independently predicted symptom reporting and reproductive outcomes. No significant association was observed between exposure intensity and abnormal blood counts. Conclusion: Questionnaire-based surveillance effectively identified exposure-related health risks, whereas routine complete blood count testing showed limited utility. Export
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
Open AccessAnalysis of a Standardized Approach to Healthcare Worker Hazardous Medication Surveillance: Lessons learned and future enhancements.
Objective: To evaluate the effectiveness of a standardized hazardous medication surveillance program and identify occupational factors associated with adverse health outcomes among healthcare workers (HCWs). Methods: We analyzed data from 2,625 HCWs enrolled in a multi-site surveillance program (2020–2022). Participants completed a standardized questionnaire and underwent complete blood count testing. Exposure was categorized by weekly time handling hazardous medications. Associations were evaluated using univariate and multivariable analyses. Results: Higher exposure (>8 hours/week) was associated with increased symptom reporting, hazardous medication spills, and adverse reproductive outcomes. Female sex, older age, and spill exposure independently predicted symptom reporting and reproductive outcomes. No significant association was observed between exposure intensity and abnormal blood counts. Conclusion: Questionnaire-based surveillance effectively identified exposure-related health risks, whereas routine complete blood count testing showed limited utility. Export
- Open Access
- 2 September 2025
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (5)
Adding employment status in the medical record demonstrates its importance as a social determinant of health
Objective: To share findings of a quality improvement initiative to capture employment status in the electronic medical record (EMR) to mitigate the potential impact of work loss on the health of patients by utilizing the results to identify eligible individuals for resources to assist return-to-work efforts. Materials and Methods: Patients self-identified employment status through a structured new social determinants of health (SDOH) question within the EMR. An electronic outreach campaign was developed to provide information via the patient portal detailing services within healthcare and the community that could benefit the patients. Results: Over the course of 12 months, 2059 patients were identified from the employment SDOH question. Resources to support stay at work and return to work efforts were provided to patients through an automated electronic portal campaign with 87% of patients reading the message and 7% engaging with a healthcare return to work case manager. Discussion: Loss of employment has detrimental impacts on individual and population health. Most EMRs do not capture information on employment status. Adding this simple question identified individuals with potential gaps in SDOH, and in this case allowed specific resources to be shared with patients with an illness or injury that was acutely impacting work. Conclusion: Medical center decision makers and EMR programmers should consider adding employment status as a social determinant of health.
- 2 September 2025
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (5)
Open AccessAdding employment status in the medical record demonstrates its importance as a social determinant of health
Objective: To share findings of a quality improvement initiative to capture employment status in the electronic medical record (EMR) to mitigate the potential impact of work loss on the health of patients by utilizing the results to identify eligible individuals for resources to assist return-to-work efforts. Materials and Methods: Patients self-identified employment status through a structured new social determinants of health (SDOH) question within the EMR. An electronic outreach campaign was developed to provide information via the patient portal detailing services within healthcare and the community that could benefit the patients. Results: Over the course of 12 months, 2059 patients were identified from the employment SDOH question. Resources to support stay at work and return to work efforts were provided to patients through an automated electronic portal campaign with 87% of patients reading the message and 7% engaging with a healthcare return to work case manager. Discussion: Loss of employment has detrimental impacts on individual and population health. Most EMRs do not capture information on employment status. Adding this simple question identified individuals with potential gaps in SDOH, and in this case allowed specific resources to be shared with patients with an illness or injury that was acutely impacting work. Conclusion: Medical center decision makers and EMR programmers should consider adding employment status as a social determinant of health.
- Open Access
- 30 January 2022
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 9 (3) , 264-275
Physical activity level and stroke risk in US population: A matched case–control study of 102,578 individuals
Background: Stroke has been linked to a lack of physical activity; however, the extent of the association between inactive lifestyles and stroke risk has yet to be characterized across large populations.Purpose: This study aimed to explore the association between activity‐related behaviors and stroke incidence.Methods: Data from 1999 to 2018 waves of the concurrent cross‐sectional National Health and Nutrition Examination Survey (NHANES) were extracted. We analyzed participants characteristics and outcomes for all participants with data on whether they had a stroke or not and assessed how different forms of physical activity affect the incidence of disease.Results: Of the 102,578 individuals included, 3851 had a history of stroke. A range of activity‐related behaviors was protective against stroke, including engaging in moderate‐intensity work over the last 30 days (OR = 0.8, 95% CI = 0.7–0.9; P = 0.001) and vigorous‐intensity work activities over the last 30 days (OR = 0.6, 95% CI = 0.5–0.8; P < 0.001), and muscle‐strengthening exercises (OR = 0.6, 95% CI = 0.5–0.8; P < 0.001). Conversely, more than 4 h of daily TV, video, or computer use was positively associated with the likelihood of stroke (OR = 11.7, 95% CI = 2.1–219.2; P = 0.022).Conclusion: Different types, frequencies, and intensities of physical activity were associated with reduced stroke incidence, implying that there is an option for everyone. Daily or every other day activities are more critical in reducing stroke than reducing sedentary behavior duration.
- 30 January 2022
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 9 (3) , 264-275
Open AccessPhysical activity level and stroke risk in US population: A matched case–control study of 102,578 individuals
Background: Stroke has been linked to a lack of physical activity; however, the extent of the association between inactive lifestyles and stroke risk has yet to be characterized across large populations.Purpose: This study aimed to explore the association between activity‐related behaviors and stroke incidence.Methods: Data from 1999 to 2018 waves of the concurrent cross‐sectional National Health and Nutrition Examination Survey (NHANES) were extracted. We analyzed participants characteristics and outcomes for all participants with data on whether they had a stroke or not and assessed how different forms of physical activity affect the incidence of disease.Results: Of the 102,578 individuals included, 3851 had a history of stroke. A range of activity‐related behaviors was protective against stroke, including engaging in moderate‐intensity work over the last 30 days (OR = 0.8, 95% CI = 0.7–0.9; P = 0.001) and vigorous‐intensity work activities over the last 30 days (OR = 0.6, 95% CI = 0.5–0.8; P < 0.001), and muscle‐strengthening exercises (OR = 0.6, 95% CI = 0.5–0.8; P < 0.001). Conversely, more than 4 h of daily TV, video, or computer use was positively associated with the likelihood of stroke (OR = 11.7, 95% CI = 2.1–219.2; P = 0.022).Conclusion: Different types, frequencies, and intensities of physical activity were associated with reduced stroke incidence, implying that there is an option for everyone. Daily or every other day activities are more critical in reducing stroke than reducing sedentary behavior duration.
- Open Access
- 14 July 2021
- Published by Wiley in Reviews in Medical Virology
- Vol. 32 (2) , e2278
The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis
Summary: Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid‐19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid‐19 or have worse outcomes. This is the first systematic review and meta‐analysis to review the impact of PD on the prognosis of Covid‐19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for Systematic Review and Meta‐analyses statement (PRISMA) guidelines. The R software version 4.0.2 was used to calculate pooled sample sizes and their associated confidence intervals (95%CI). Finally, we included 13 papers in this study. The pooled prevalence rate of Covid‐19 was 2.12% (95%CI: 0.75–5.98). Fever, cough, fatigue and anorexia were the most common symptoms with a rate of 72.72% (95% CI: 57.3 ‐ 92.29), 66.99% (95% CI: 49.08–91.42), 61.58% (95% CI: 46.69–81.21) and 52.55% (95% CI: 35.09–78.68), respectively. The pooled rates were 39.89% (95% CI: 27.09–58.73) for hospitalisation, 4.7% (95% CI: 1.56–14.16) for ICU admission and 25.1% (95%CI: 16.37–38.49) for mortality. On further comparison of hospitalisation and mortality rates among Covid‐19 patients with and without PD, there were no significant differences. In conclusion, the prevalence and prognosis of Covid‐19 patients seem comparable in patients with PD and those without it. The increased hospitalisation and mortality may be attributed to old age and co‐morbidities.
- 14 July 2021
- Published by Wiley in Reviews in Medical Virology
- Vol. 32 (2) , e2278
Open AccessThe impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis
Summary: Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid‐19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid‐19 or have worse outcomes. This is the first systematic review and meta‐analysis to review the impact of PD on the prognosis of Covid‐19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for Systematic Review and Meta‐analyses statement (PRISMA) guidelines. The R software version 4.0.2 was used to calculate pooled sample sizes and their associated confidence intervals (95%CI). Finally, we included 13 papers in this study. The pooled prevalence rate of Covid‐19 was 2.12% (95%CI: 0.75–5.98). Fever, cough, fatigue and anorexia were the most common symptoms with a rate of 72.72% (95% CI: 57.3 ‐ 92.29), 66.99% (95% CI: 49.08–91.42), 61.58% (95% CI: 46.69–81.21) and 52.55% (95% CI: 35.09–78.68), respectively. The pooled rates were 39.89% (95% CI: 27.09–58.73) for hospitalisation, 4.7% (95% CI: 1.56–14.16) for ICU admission and 25.1% (95%CI: 16.37–38.49) for mortality. On further comparison of hospitalisation and mortality rates among Covid‐19 patients with and without PD, there were no significant differences. In conclusion, the prevalence and prognosis of Covid‐19 patients seem comparable in patients with PD and those without it. The increased hospitalisation and mortality may be attributed to old age and co‐morbidities.
- 30 November 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 19 (5) , 661-669
Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis
Objective: To examine the safety and efficacy of hyeprimmunoglobulin therapy on vertical transmission of congenital cytomegalovirus (CCMV). Method: We searched nine databases for studies investigating the effect of Hyperimmunoglobulin among pregnant women with CMV. Results: Of total eight studies, the pooled prevalence of CCMV was 36.5% (95% confidence intervals (CI): 26-49%). There was no evidence that hyperimmunoglobulin is effective against CCMV [odds ratio (OR) (95% (CI)) = 0.53 (0.20-1.42)]. However, analysing only studies of pregnant women with confirmed primary infection, a significant reduction in the congenital CCMV rates was observed [OR (95% CI) = 0.33 (0.18-0.59)]. Based on the purpose, CCMV prevention was successful with a reduction of the CCMV rates [OR (95% CI) = 0.33 (0.16-0.68)[, while treatment was not]OR (95% CI) = 0.80 (0.04-15.01)]. The most common adverse pregnancy outcome was prematurity, followed by intrauterine growth retardation (IUGR) and termination of pregnancy (TOP), with no significant impact of antenatal hyperimmunoglobulin usage. Conclusion: Our results showed a promising efficacy of hyperimmunoglobulin therapy among pregnant women with confirmed primary infection, which fades away on including secondary infection. This effectiveness was limited to the prevention, not the treatment, of CCMV. More randomized controlled trials are needed to provide concrete evidence.
- 30 November 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 19 (5) , 661-669
Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis
Objective: To examine the safety and efficacy of hyeprimmunoglobulin therapy on vertical transmission of congenital cytomegalovirus (CCMV). Method: We searched nine databases for studies investigating the effect of Hyperimmunoglobulin among pregnant women with CMV. Results: Of total eight studies, the pooled prevalence of CCMV was 36.5% (95% confidence intervals (CI): 26-49%). There was no evidence that hyperimmunoglobulin is effective against CCMV [odds ratio (OR) (95% (CI)) = 0.53 (0.20-1.42)]. However, analysing only studies of pregnant women with confirmed primary infection, a significant reduction in the congenital CCMV rates was observed [OR (95% CI) = 0.33 (0.18-0.59)]. Based on the purpose, CCMV prevention was successful with a reduction of the CCMV rates [OR (95% CI) = 0.33 (0.16-0.68)[, while treatment was not]OR (95% CI) = 0.80 (0.04-15.01)]. The most common adverse pregnancy outcome was prematurity, followed by intrauterine growth retardation (IUGR) and termination of pregnancy (TOP), with no significant impact of antenatal hyperimmunoglobulin usage. Conclusion: Our results showed a promising efficacy of hyperimmunoglobulin therapy among pregnant women with confirmed primary infection, which fades away on including secondary infection. This effectiveness was limited to the prevention, not the treatment, of CCMV. More randomized controlled trials are needed to provide concrete evidence.
- 1 September 2020
- Published by Elsevier in Heart & Lung
- Vol. 49 (5) , 512-517
Association between sarcoidosis and cardiovascular comorbidity: A systematic review and meta-analysis
- 1 September 2020
- Published by Elsevier in Heart & Lung
- Vol. 49 (5) , 512-517
Association between sarcoidosis and cardiovascular comorbidity: A systematic review and meta-analysis
- 1 August 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 415, 116890
Primary cerebral lymphoma' characteristics, incidence, survival, and causes of death in the United States
- 1 August 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 415, 116890
Primary cerebral lymphoma' characteristics, incidence, survival, and causes of death in the United States
- 1 June 2020
- Published by Elsevier in Physiotherapy
- Vol. 107, 176-188
Efficacy of kinesio taping in treatment of shoulder pain and disability: a systematic review and meta-analysis of randomised controlled trials
- 1 June 2020
- Published by Elsevier in Physiotherapy
- Vol. 107, 176-188
Efficacy of kinesio taping in treatment of shoulder pain and disability: a systematic review and meta-analysis of randomised controlled trials
- 6 December 2019
- Published by Wiley in Reviews in Medical Virology
- Vol. 30 (3) , e2089
Therapeutic efficacy of hepatitis B virus vaccine in treatment of chronic HBV infections: A systematic review and meta‐analysis
Summary: There is a need for improved treatment of patients with chronic hepatitis B (CHB). We reviewed the literature to explore the efficacy of HB vaccines alone or in combination therapy (CT) with antiviral drugs in CHB patients and to meta‐analyze data from randomized controlled trials. We conducted a systematic search in ten databases. All studies investigating the efficacy of HBV vaccine in HBV infected patients were included with no restrictions. Among 1359 studies initially identified, 23 studies (n = 1956 patients) were included for the final analysis. CT showed a significant reduction of HBV DNA compared with analogue monotherapy (AM) at the 12‐month follow‐up period (odds ratio (OR) = 2.835, 95% confidence interval (CI) [1.275, 6.306], p = .011). Additionally, CT also remarkably induce HbsAg loss in comparison with AM (OR = 11.736, 95% CI [1.841, 74.794], p = .009). Our pooled data revealed no difference between treatment and control regarding alanine aminotransferase normalization, HBeAg seroconversion, and HBeAg disappearance. In addition, CT using vaccine and NAs resulted in a statistically significant higher incidence of adverse effects than AM. The therapeutic effects of combination therapy for patients with CHB were encouraging, but future studies need to investigate all possible treatment combinations and assess their cost‐effectiveness.
- 6 December 2019
- Published by Wiley in Reviews in Medical Virology
- Vol. 30 (3) , e2089
Therapeutic efficacy of hepatitis B virus vaccine in treatment of chronic HBV infections: A systematic review and meta‐analysis
Summary: There is a need for improved treatment of patients with chronic hepatitis B (CHB). We reviewed the literature to explore the efficacy of HB vaccines alone or in combination therapy (CT) with antiviral drugs in CHB patients and to meta‐analyze data from randomized controlled trials. We conducted a systematic search in ten databases. All studies investigating the efficacy of HBV vaccine in HBV infected patients were included with no restrictions. Among 1359 studies initially identified, 23 studies (n = 1956 patients) were included for the final analysis. CT showed a significant reduction of HBV DNA compared with analogue monotherapy (AM) at the 12‐month follow‐up period (odds ratio (OR) = 2.835, 95% confidence interval (CI) [1.275, 6.306], p = .011). Additionally, CT also remarkably induce HbsAg loss in comparison with AM (OR = 11.736, 95% CI [1.841, 74.794], p = .009). Our pooled data revealed no difference between treatment and control regarding alanine aminotransferase normalization, HBeAg seroconversion, and HBeAg disappearance. In addition, CT using vaccine and NAs resulted in a statistically significant higher incidence of adverse effects than AM. The therapeutic effects of combination therapy for patients with CHB were encouraging, but future studies need to investigate all possible treatment combinations and assess their cost‐effectiveness.